Correlation of human cold pressor pain responses with 5-HT1A receptor binding in the brain

Brain Research

Volumn 1172, Issue 1, 2007, Pages 21-31

  Martikainen, Ilkka K ^a   Hirvonen, Jussi ^a,b   Kajander, Jaana ^a   Hagelberg, Nora ^a,b   Mansikka, Heikki ^a,b   Någren, Kjell ^a   Hietala, Jarmo ^a,b   Pertovaara, Antti ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

carbonyl 11C WAY 100635; Pain modulation; Positron emission tomography; Sympathetic vasoconstriction

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; RADIOISOTOPE; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN; CINGULATE GYRUS; COLD PRESSOR TEST; CONDITIONING; DORSAL RAPHE NUCLEUS; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NORMAL HUMAN; PAIN; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SYMPATHETIC REFLEX; VALSALVA MANEUVER; VASOCONSTRICTION;

ADULT; ANALYSIS OF VARIANCE; BRAIN; CARBON RADIOISOTOPES; COLD; HUMANS; MALE; PAIN; PAIN THRESHOLD; PIPERAZINES; PSYCHOPHYSICS; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 34548702469     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.036     Document Type: Article

References (65)

1. Anthony M., and Lance J.W. Plasma serotonin in patients with chronic tension headaches. J. Neurol. Neurosurg. Psychiatry 52 (1989) 182-184
2. Aragona M., Bancheri L., Perinelli D., Tarsitani L., Pizzimenti A., Conte A., and Inghilleri M. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatiens with somatoform, DSM-IV-TR pain disorder. Eur. J. Pain 9 (2005) 33-38
3. Arnold L.M., Hess E.V., Hudson J.I., Welge J.A., Berno S.E., and Keck P.E. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am. J. Med. 112 (2002) 191-197
4. Azmitia E.C., and Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179 (1978) 641-667
5. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14 (1996) 35-46
6. Broekaert D., Fischler B., Sifrim D., Janssens J., and Tack J. Influence of citalopram, a selective serotonin reuptake inhibitor on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment. Pharm. Ther. 23 (2006) 365-370
7. Bushnell M.C., and Apkarian A.V. Representation of pain in the brain. In: McMahon S.B., and Koltzenburg M. (Eds). Wall and Melzack's Textbook of Pain. 5th ed. (2006), Elsevier, China 107-124
8. 1A receptors. Psychopharmacology (Berl.) 149 (2000) 259-268
9. Casey K.L., and Tran T.D. Cortical mechanisms mediating acute and chronic pain in humans. In: Cervero F., and Jensen T.S. (Eds). Handbook of Clinical Neurology vol. 81 (2006), Elsevier, Amsterdam 159-177
10. 1A receptor activation: new molecular and neuroadaptive mechanisms of pain relief. Curr. Opin. Investig. Drugs 7 (2006) 40-47
11. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology (2003), Oxford University Press, New York
12. Critchley H.D., Mathias C.J., Josephs O., O'Doherty J., Zanini S., Dewar B.K., Cipolotti L., Shallice T., and Dolan R.J. Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain 126 (2003) 2139-2152
13. David S.P., Murthy N.V., Rabiner E.A., Munafó M.R., Johnstone E.C., Jacob R., Walton R.T., and Grasby P.M. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25 (2005) 2586-2590
14. 1-type receptor mediates the antinociceptive effect of nucleus raphe magnus stimulation in the rat. Brain Res. 523 (1990) 92-99
15. Farde L., Ito H., Swahn C.G., Pike V.W., and Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. J. Nucl. Med. 39 (1998) 1965-1971
16. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2 (1995) 189-210
17. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281 (1995) 81-88
18. Goldenberg D., Mayskiy M., Mossey C., Ruthazer R., and Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 39 (1996) 1852-1859
19. Graeff F.G., Guimarães F.S., De Andrade T.G.C.S., and Deakin J.F.W. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54 (1996) 129-141
20. Green A.L., Wang S., Owen S.L.F., Xie K., Bittar R.G., Stein J.F., Paterson D.J., and Aziz T.Z. Stimulating the human midbrain to reveal the link between pain and blood pressure. Pain 124 (2006) 349-359
21. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Någren K., Hietala J., Scheinin H., and Pertovaara A. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99 (2002) 273-279
22. Henderson L.A., Macey P.M., Macey K.E., Frysinger R.C., Woo M.A., Harper R.K., Alger J.R., Yan-Go F.L., and Harper R.M. Brain responses associated with the Valsalva maneuver revealed by functional magnetic resonance imaging. J. Neurophysiol. 88 (2002) 3477-3486
23. 11C]WAY-100635-considerations on the validity of cerebellum as a reference region. J. Cereb. Blood Flow Metab. 27 (2007) 185-195
24. Hornung J.P. The human raphe nuclei and the serotoninergic system. J. Chem. Neuroanat. 26 (2003) 331-343
25. Kemppainen P., Leppänen H., Jyväsjärvi E., and Pertovaara A. Blood flow increase in the orofacial area of humans induced by painful stimulation. Brain Res. Bull. 33 (1994) 655-662
26. 1A receptor antagonist, to rat-brain. J. Neurochem. 64 (1995) 2716-2726
27. Kilkens T.O.C., Honig A., van Nieuwenhoven M.A., Riedel W.J., and Brummer R.J.M. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut 53 (2004) 1794-1800
28. Kulkarni B., Bentley D.E., Elliott R., Youell P., Watson A., Derbyshire S.W.G., Frackowiak R.S.J., Friston K.J., and Jones A.K.P. Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems. Eur. J. Neurosci. 21 (2005) 3133-3142
29. 1A receptors. J. Pharmacol. Exp. Ther. 276 (1996) 958-967
30. 1A receptors in the descending anti-nociceptive pathway from the periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve injury and rats with inflammation. Neuroscience 112 (2002) 399-407
31. Macefield V.G., Gandevia S.C., and Henderson L.A. Neural sites involved in the sustained increase in muscle sympathetic nerve activity induced by inspiratory capacity apnea: a fMRI study. J. Appl. Physiol. 100 (2006) 266-273
32. Martikainen I.K., Närhi M.V., and Pertovaara A. Spatial integration of cold pressor pain sensation in humans. Neurosci. Lett. 361 (2004) 140-143
33. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., and Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29 (2004) 2258-2265
34. Meyer J.H., Gunn R.N., Myers R., and Grasby P.M. Assessment of spatial normalization of PET ligand images using ligand-specific templates. NeuroImage 9 (1999) 545-553
35. 1A receptors in research strategy for extensive pain treatment. Curr. Top. Med. Chem. 6 (2006) 1997-2003
36. 11C]methyl-l-tryptophan, positron emission tomography and statistical parametric mapping. Can. J. Gastroenetrol. 17 (2003) 191-196
37. Neugebauer V. Subcortical processing of nociceptive information: basal ganglia and amygdala. In: Cervero F., and Jensen T.S. (Eds). Handbook of Clinical Neurology vol. 81 (2006), Elsevier, Amsterdam 141-158
38. Nurmikko T., Pertovaara A., Pöntinen P.J., Marnela K.M., and Oja S.S. Effect of l-tryptophan supplementation on ischemic pain. Acupunct. Electro-ther. Res. 9 (1984) 45-55
39. Öberg P.Å. Laser-Doppler flowmetry. Crit. Rev. Biomed. Eng. 18 (1990) 125-163
40. 11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J. Cereb. Blood Flow Metab. 20 (2000) 1111-1133
41. 1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 954 (2002) 173-182
42. 1A receptors in human cerebellum as assessed by positron emission tomography. J. Cereb. Blood Flow Metab. 25 (2005) 785-793
43. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y., van Heertum R.L., Arango V., and Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiatry 59 (2006) 106-113
44. Peckerman A., Saab P.G., McCabe P.M., Skyler J.S., Winters R.W., Llabe M.M., and Schneiderman N. Blood pressure reactivity and perception of pain during the forehead cold pressor test. Psychophysiology 28 (1991) 485-495
45. Pickering G., Januel F., Dubray C., and Eschalier A. Serotonin and experimental pain in healthy young volunteers. Clin. J. Pain 19 (2003) 276-279
46. 1A receptors in human brain with PET and [carbonyl-C-11]WAY-100635. Eur. J. Pharmacol. 301 (1996) R.5-R.7
47. 1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. NeuroImage 15 (2002) 620-632
48. Rainville P., Feine J.S., Bushnell M.C., and Duncan G.H. A psychophysical comparison of sensory and affective responses to four modalities of experimental pain. Somatosens. Mot. Res. 9 (1992) 265-277
49. 1A receptor agonists on sympathetic and parasympathetic nerve activity. J. Cardiovasc. Pharmacol. 15 Suppl. 7 (1990) S75-S85
50. Rani P.U., Naidu M.U., Prasad V.B.N., Rao T.R., and Shobha J.C. An evaluation of antidepressants in rheumatic pain conditions. Anesth. Analg. 83 (1996) 371-375
51. Richerson G.B. The autonomic system. In: Boron W.F., and Boulpaep E.L. (Eds). Medical Physiology (2003), Saunders, Philadelphia 378-398
52. Rivot J.P., Weil-Fugazza J., Godefroy F., Bineau-Thurotte M., Ory-Lavollée L., and Besson J.M. Involvement of serotonin in both morphine and stimulation-produced analgesia: electrochemical and biochemical approaches. Adv. Pain Res. Ther. 6 (1984) 135-150
53. Rowbotham M.C., Reisner L.A., Davies P.S., and Fields H.L. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J. Pain 6 (2005) 741-746
54. Sindrup S.H., Gram L.F., Brøsen K., Eshøj O., and Mogensen E.F. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 (1990) 135-144
55. Slifstein M., and Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl. Med. Biol. 28 (2001) 595-608
56. Tack J., Broekaert D., Fischler B., Van Oudenhove L., Gevers A.M., and Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 55 (2006) 1095-1103
57. Tiihonen J., Keski-Rahkonen A., Löppönen M., Muhonen M., Kajander J., Allonen T., Någren K., Hietala J., and Rissanen A. Brain serotonin 1A receptor binding in bulimia. Biol. Psychiatry 55 (2004) 871-873
58. Vahedi H., Merat S., Rashidioon A., Ghoddoosi A., and Malekzadeh R. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment. Pharmacol. Ther. 22 (2005) 381-385
59. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev., Neurosci. 6 (2005) 533-544
60. Wallin B.G. Neural control of human skin blood flow. J. Auton. Nerv. Syst. 30 (1990) S185-S190 Suppl
61. Wang Q.P., and Nakai Y. The dorsal raphe: an important nucleus in pain modulation. Brain Res. Bull. 34 (1994) 575-585
62. 1A receptors in endogenous regulation of neuropathic hypersensitivity in the rat. Eur. J. Pharmacol. 535 (2006) 157-165
63. Wolfe F., Russell I.J., Vipraio G., Ross K., and Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J. Rheumatol. 24 (1997) 555-559
64. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., and Jennes L. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351 (1995) 357-373
65. 11C]McN 5652 dynamic PET with parametric imaging approach. NeuroImage 22 Suppl. 2 (2004) T98